PAVmed Inc. Relocates Principal Executive Offices
Ticker: PAVM · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1624326
Sentiment: neutral
Topics: administrative, corporate-action
TL;DR
PAVmed moved offices to 360 Madison Ave, NYC. No major financial news.
AI Summary
PAVmed Inc. filed an 8-K on July 30, 2025, reporting an event that occurred on July 29, 2025. The filing indicates a change in the company's principal executive offices to 360 Madison Avenue, 25th Floor, New York, NY 10017. The company's former name was PAXmed Inc., with a name change occurring on November 5, 2014.
Why It Matters
A change in principal executive offices can signal operational shifts or strategic decisions within the company. Investors should monitor if this move impacts operational efficiency or costs.
Risk Assessment
Risk Level: low — The filing primarily concerns a change of address for the company's principal executive offices, which is a routine administrative event.
Key Players & Entities
- PAVmed Inc. (company) — Registrant
- PAXmed Inc. (company) — Former company name
- July 29, 2025 (date) — Date of earliest event reported
- July 30, 2025 (date) — Filing date
- 360 Madison Avenue, 25th Floor, New York, NY 10017 (location) — New principal executive offices
FAQ
What is the new address for PAVmed Inc.'s principal executive offices?
The new address for PAVmed Inc.'s principal executive offices is 360 Madison Avenue, 25th Floor, New York, NY 10017.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 29, 2025.
What was PAVmed Inc.'s former company name?
PAVmed Inc.'s former company name was PAXmed Inc.
When did the name change from PAXmed Inc. to PAVmed Inc. occur?
The name change from PAXmed Inc. to PAVmed Inc. occurred on November 5, 2014.
What is the filing date of this 8-K report?
This 8-K report was filed on July 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding PAVmed Inc. (PAVM).